C
RYTM icon

Covestor’s Rhythm Pharmaceuticals RYTM Stock Holding History

Covestor’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20K Sell
179
-66
-27% -$5.97K 0.01% 1180
2026
Q1 		$21K Sell
245
-334
-58% -$32.5K 0.01% 1095
2025
Q4 		$62K Buy
579
+444
+329% +$47.1K 0.03% 830
2025
Q3 		$14K Buy
135
+130
+2,600% +$12.1K 0.01% 1438
2025
Q2 		$0 Sell
5
-1
-17% -$61 ﹤0.01% 2678
2025
Q1 		$0 Sell
6
-4
-40% -$222 ﹤0.01% 2660
2024
Q4 		$1K Buy
10
+7
+233% +$387 ﹤0.01% 2119
2024
Q3 		$0 Hold
3
– – ﹤0.01% 2682
2024
Q2 		$0 Hold
3
– – ﹤0.01% 2679
2024
Q1 		$0 Sell
3
-1
-25% -$44 ﹤0.01% 2662
2023
Q4 		$0 Sell
4
-3
-43% -$95 ﹤0.01% 2636
2023
Q3 		$0 Buy
+7
New +$157 ﹤0.01% 2626

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Covestor's RYTM Position: Q2 2026 in Review

Covestor reduced its Rhythm Pharmaceuticals (RYTM) stake by 27% in Q2 2026, selling an estimated $5.97K and leaving 179 shares worth $20K. The position accounts for 0.01% of the portfolio, ranked #1180.

Covestor first reported a position in RYTM in Q3 2023 and has held it in 12 quarters since. The position peaked at $62K in Q4 2025. 303 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Covestor held 179 shares of Rhythm Pharmaceuticals worth $20K as of Q2 2026.
  • Covestor sold 66 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $5.97K.
  • Rhythm Pharmaceuticals made up 0.01% of Covestor's portfolio in Q2 2026, its #1180 holding.
  • Covestor first reported a position in Rhythm Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
  • Covestor's Rhythm Pharmaceuticals position peaked at $62K in Q4 2025.
  • 303 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.